Linerixibat is an ileal bile acid transporter (IBAT) inhibitor indicated for the treatment of cholestatic pruritus in adult patients with primary biliary cholangitis. By inhibiting the reabsorption of… Read more
Linerixibat is an ileal bile acid transporter (IBAT) inhibitor indicated for the treatment of cholestatic pruritus in adult patients with primary biliary cholangitis. By inhibiting the reabsorption of bile acids in the terminal ileum, this small-molecule drug facilitates their excretion, thereby reducing the systemic bile acid levels that contribute to severe itching. Our catalogue for this category features high-quality reference standards, including stable isotope labelled compounds such as Linerixibat-d4 and Linerixibat-d5. These materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling, quantitative analysis, and method validation. Using these precise reference standards enables accurate quality control and the consistent assessment of drug purity throughout the analytical development process.